Background: Clinical and radiographic status around short dental implants in patients with
| INTRODUCTION
The concept of osseointegration has resulted in the overall long-term survival of standard length dental implants. The length of standard dental implants measure at least 10 mm (mm) and are generally used to replace missing teeth in partial and/or complete edentulism. 1, 2 However, atrophic jaws may require advanced forms of surgical procedures such as autogenous bone grafts, sinus augmentation, and distraction osteogenesis that helps to augment bone height. 3, 4 In addition, patients are prudent to these complex surgical techniques in terms of cost, donor site morbidity, and surgical treatment time. 5 To avoid these surgical techniques, short implants which measure 6-8 mm in length were introduced. 6, 7 Clinical trials have reported that short dental implants may offer predictable outcomes in a manner similar to standard length implants. [8] [9] [10] Moreover, results from a recent meta-analysis suggests that implant survival, radiographic bone loss (RBL), biological, and technical complications are comparable between short and standard length dental implants. 10 Dental implant success is determined by the maintenance of periimplant bone level. The overall success certainly depends on a number of factors including oral hygiene care, smoking, and smokeless tobacco use, chronic systemic inflammatory response such as obesity and type-2 diabetes mellitus (T2DM). [11] [12] [13] [14] [15] Chronic hyperglycemia is considered as a typical risk-factor that causes soft tissue inflammation and RBL around natural teeth and implants. 16 One possible explanation for this mechanism is that chronic hyperglycemia has the propensity to increase the levels of accumulated glycation end products (AGEs) in the serum and oral tissues that accelerates the production of proinflammatory cytokines that induce bone destruction around natural teeth and implants. 17, 18 However, it is relevant to indicate that dental implants in chronic hyperglycemia under ideal glycemic conditions can successfully osseointegrate and show predictable outcomes over long durations in both diabetic and non-diabetic patients.
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Recent data on clinical and radiographic peri-implant status in different glycemic levels suggests these parameters are significantly poor in patients with high glycemic levels as compared to controlled glycemic patients. 16, 20 However, a paucity of data on the findings of short dental implants exists among patients with different glycemic levels.
We hypothesized that clinical and radiographic peri-implant parame- and RBL) are worse around short dental implants in patients with high glycemic levels as compared to non-diabetic patients. Hence, the aim of this retrospective cross-sectional study was to determine the clinical and RBL around short dental implants in T2DM, prediabetic, and non-diabetic patients.
| MATERIALS AND METHODS

| Ethical protocol
The study guidelines agree with the guidelines formed by the Declaration of Helsinki. An information sheet was provided in two languages (English and Arabic) that explained the aims and methodology designed to all the individuals. Volunteering participants had the right to retract their participation at any step of the research study without any penalty. Ethical approval was obtained from Ethics Research Committee of Centre for Specialist Dental Practice and Clinical Research.
| Eligibility criteria
Patients were included in the study with; (a) medically diagnosed T2DM 
| Study groups
The study was conducted from November 2016 to August 2017. Participants were grouped into three groups based on HbA1c levels:
(a) T2DM (Group-1); (b) prediabetic patients (Group-2); and (c) nondiabetic subjects (Group-3). Self-reporting subjects to have T2DM or prediabetes were requested to show their diabetic records for verification of serum HbA1c levels.
| Research questionnaire
All participants filled a baseline research questionnaire administered by a trained assessor. The questionnaire included information regarding, age, gender, duration of dental implants service, duration of diabetic status, family history of T2DM, treatment of T2DM or prediabetes recommended by healthcare personnel, and daily tooth brushing.
| Clinical peri-implant and periodontal measurements
All clinical recordings around short dental implants were assessed by a blinded, expert evaluator with compliant intra-examiner reliability 
| Radiographic analysis
Standardized periapical digital radiographs were taken using Romexis software (images saved at 1:1 ratio) and examined on a calibrated 
| Estimation of hemoglobin A1c levels and lipid parameters
Serum glycemic status was evaluated through medical record examination and a fresh HbA1c assessment was carried out to measure the profile of HbA1c of the previous 3 months. Non-diabetic status was also ratified through performing HbA1c test. Three groups were categorized in accordance with the classification presented by American Diabetes Association. 21 Chair-side HbA1c levels were measured using an HbA1c analyzer kit (Quo-Test, EKF Diagnostics, Magdeburg, Germany) for all three groups. Serum samples were drawn from the all the participants in the morning via venipuncture from antecubital vein.
Samples were collected in vacutainer tubes with a gel separator and in heparinized tubes for HbA1c recordings and incubated for 30 minutes. The samples were then centrifuged at 2000 rpm for 15 minutes at 4 C. In addition, lipid parameters were measured in the serum samples including triglycerides and total cholesterol.
All patients in T2DM and prediabetes groups were advised by their medical physicians to control blood glucose levels via dietary advice. All participants in T2DM group were recommended antidiabetic medications for the treatment of T2DM and were also advised to observe dietary control.
| Statistical design
Statistical analysis was performed using a software program (SPSS v.18, IBM, Chicago, Illinois). Clinical and radiographic peri-implant and periodontal parameters among patients with T2DM, prediabetes and no diabetes were assessed using Kruskall-Wallis test. For multiple comparisons, Bonferroni post hoc adjustment test was used. Logistic regression analysis was employed to identify explanatory variables for peri-implant outcomes, controlling for the effect of possible covariates such as HbA1c, total cholesterol levels, triglyceride levels, and BMI.
The direction and strength of association between RBL and covariates were assessed by generating odds ratios, the precision of which could be measured by 95% confidence intervals. P-values <.05 were considered statistically significant.
3 | RESULTS 
| General description of the study groups
| Clinical and radiographic peri-implant parameters
Clinical peri-implant parameters including PI (P < .01) and BOP (P < .01) were statistically significantly higher in group-1 as compared to group-3. PI (P < .05) and BOP (P < .05) were significantly higher in group-2 as compared to group-3. Mean PD was statistically significantly higher in group-1 patients compared to group-3 (P < .01). Mean PD was higher in prediabetes group as compared to non-diabetic, however, the difference was not statistically significant. RBL was significantly higher in both group-1 (P < .01) and group-2 (P < .05)
patients as compared to patients in group 3 ( Table 2 ).
| Periodontal parameters
Clinical periodontal parameters and their scores are shown in Table 3 .
Periodontal PI, BOP, PD, CAL, and RBL were statistically significantly higher among patients in groups 1 (P < .01) and 2 (P < .05) compared with group-3. Clinical scores of mean PI, BOP, PD, CAL, and RBL among patients in groups 1 and 2 were comparable (Table 3) .
| Regression analysis to control HbA1c, lipid parameters, and BMI
RBL is considered a strong indicator of peri-implant tissue inflammation, therefore, HbA1c, total cholesterol, triglyceride levels, and BMI were adjusted taking RBL into consideration only. The regression analysis revealed that RBL showed statistically significant difference among T2DM patients even after adjusting for HbA1c, total cholesterol, and BMI for group-1 (P < .05). RBL showed statistically significant difference in prediabetic patients after adjusting for only HbA1c in group-2 (P < .05; Table 4 ). High level of inflammation around peri-implant tissues in high glycemic level patients could be due to several biomolecular reasons.
One possible mechanism could be due to the excess accumulation of AGEs that are formed by nonenzymatic glycosylation of several proteins in the serum of diabetes mellitus patients. 25 Increased levels of AGEs further induce the production of receptors of AGEs. 26 This interaction leads to the production of several types of destructive proinflammatory cytokines such as interleukin-6 and collagenases (matrix metalloproteinase) that are produced by periodontal and periimplant gingival fibroblasts and are responsible for periodontal and peri-implant tissue inflammation and destruction. 27, 28 The present study analyzed a number of parameters related to peri-implant soft and hard tissue health. Mean peri-implant plaque levels were statistically significantly higher among T2DM and prediabetic patients as compared to non-diabetic patients. These findings could be attributed with twice daily brushing reported by almost 29%
by non-diabetic patients and therefore, low levels of plaque were seen around these implants. Moreover, mean BOP was also higher among patients with T2DM and prediabetes. These findings corroborate with the findings presented by Gomez-Moreno and colleagues 20 that showed high bleeding tendency in patients with higher HbA1c levels.
Another recent cross-sectional study proved that prediabetic and diabetic states are associated with increased BOP tendency. 29 It is also note-worthy that mean peri-implant PD around short implants was statistically significantly higher in T2DM patients as compared to prediabetic and non-diabetic patients. This suggests that mean PD were not deep enough to label them pathologic in T2DM.
In the present study, clinical periodontal parameters including PD and clinical attachment level were compromised in recruited cohort.
Most notably, patients with a history of chronic periodontitis have been documented to present with increased risk for peri-implant inflammation. 30, 31 Early investigations have reported that the microbiota around failing implants and periodontally involved teeth yield similar bacterial compositions, characterized by a high proportion of gram-negative anaerobic rods. 32, 33 The present study did not assess microbiological profile among patients with peri-implant inflammation and periodontal infection. However, future studies reporting microbiological profile among peri-implant inflammation and level of periodontitis should be assessed among diabetic and prediabetic subjects in order to obtain strong inferences.
Another remarkable finding in the present study is that the patients in T2DM and prediabetes groups had increased mean BMI in the present study only short dental implants were studied. The Furthermore, survival rates and success rates were not analyzed in the present study which actually determines true clinical performance of the dental implants. Further longitudinal studies are warranted to evaluate the evolution of inflammation/destruction of soft and hard tissues around short dental implants.
| CONCLUSION
Clinical and radiographic peri-implant parameters are compromised around short dental implants in type-2 diabetes mellitus patients. Further longitudinal studies are needed to compare clinical performance of short dental implants with standard dental implants placed in patients with different glycemic level.
